# Clinical Study of Individualized Vancomycin Dosing Based on Population PK Model

> **NCT06161870** · PHASE4 · RECRUITING · sponsor: **Central South University** · enrollment: 112 (estimated)

## Conditions studied

- Severe Infection

## Interventions

- **DRUG:** individualized vancomycin dosing based on the population pharmacokinetics (PK) model
- **DRUG:** empirical vancomycin dosing

## Key facts

- **NCT ID:** NCT06161870
- **Lead sponsor:** Central South University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-01-01
- **Primary completion:** 2024-12
- **Final completion:** 2024-12
- **Target enrollment:** 112 (ESTIMATED)
- **Last updated:** 2023-12-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06161870

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06161870, "Clinical Study of Individualized Vancomycin Dosing Based on Population PK Model". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06161870. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*